Company Overview

Company name: Teewinot Life Sciences
Description: Developer of patented bio-synthetic manufacturing biotechnology methods designed to offer naturally-occurring cannabinoids and cannabinoid prodrugs. The company’s methods help to improve human therapies and support to advance medical research and product development, enabling healthcare providers to address therapeutics and wellness needs of the patients.
Year founded: 2015
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.tlscorp.com
Employees: 20
City: Tampa
State: Florida
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 19.29
Business status: Startup
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised venture funding from undisclosed investors on May 1, 2017. Previously, the company raised $12.29 million of Series B venture funding in a deal led by Tuatara Capital on March 1, 2017, putting the company’s pre-money valuation at $125.71 million. Other undisclosed investors also participated in the round.
Number of active investors:
Profile last updated: 02-Oct-2018
Last known valuation: 168.00
Last known valuation date: 01-May-2017